Literature DB >> 9918339

A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes.

J M Graham1, H J Sagar.   

Abstract

Idiopathic Parkinson's disease (IPD) has been subclassified on the basis of predominant motor symptomatology, age at disease onset, depressive affect, and cognitive performance. However, subgroups are usually arbitrarily defined and not reliably based on qualitatively distinct neuropathology. We explored heterogeneity in IPD in a data-driven manner using comprehensive demographic, motor, mood, and cognitive information collected from 176 patients with IPD. Cluster analysis revealed three subgroups of patients at a disease duration of 5.6 years and two subgroups at 13.4 years. The subgroups may represent the clinical progression of three distinct subtypes of IPD. The "motor only" subtype was characterized by motor symptom progression in the absence of intellectual impairment. Equivalent motor symptom progression was shown by the "motor and cognitive" subtype which was accompanied by executive function deficits progressing to global cognitive impairment. The "rapid progression" subtype was characterized by an older age at disease onset and rapidly progressive motor and cognitive disability. There was no relationship between the motor and cognitive symptoms in any subtype of IPD. We conclude that the clinical heterogeneity of IPD is governed by distinct neuropathologic processes with independent etiologic influences.

Entities:  

Mesh:

Year:  1999        PMID: 9918339     DOI: 10.1002/1531-8257(199901)14:1<10::aid-mds1005>3.0.co;2-4

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  42 in total

1.  Pattern of extrapyramidal signs in Alzheimer's disease.

Authors:  Giuseppe Tosto; Sarah E Monsell; Stephen E Hawes; Richard Mayeux
Journal:  J Neurol       Date:  2015-09-04       Impact factor: 4.849

2.  Past appendectomy may be related to early cognitive dysfunction in Parkinson's disease.

Authors:  Alexandra R Gonçalves; Alexandre Mendes; Nuno Vila-Chã; Joana Damásio; Joana Fernandes; Sara M Cavaco
Journal:  Neurol Sci       Date:  2020-06-11       Impact factor: 3.307

3.  Relationship between age and subtypes of psychotic symptoms in Parkinson's disease.

Authors:  Günes Kiziltan; Sibel Ozekmekçi; Sibel Ertan; Turan Ertan; Ethem Erginöz
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

4.  Clinical heterogeneity in newly diagnosed Parkinson's disease.

Authors:  Bart Post; Johannes D Speelman; Rob J de Haan
Journal:  J Neurol       Date:  2008-03-17       Impact factor: 4.849

5.  Clinical heterogeneity in patients with early-stage Parkinson's disease: a cluster analysis.

Authors:  Ping Liu; Tao Feng; Yong-jun Wang; Xuan Zhang; Biao Chen
Journal:  J Zhejiang Univ Sci B       Date:  2011-09       Impact factor: 3.066

6.  Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease.

Authors:  Ilknur Telkes; Ashwin Viswanathan; Joohi Jimenez-Shahed; Aviva Abosch; Musa Ozturk; Akshay Gupte; Joseph Jankovic; Nuri F Ince
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-21       Impact factor: 11.205

7.  Motor subtype changes in early Parkinson's disease.

Authors:  Robert S Eisinger; Christopher W Hess; Daniel Martinez-Ramirez; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  Parkinsonism Relat Disord       Date:  2017-07-21       Impact factor: 4.891

8.  Syndromic approach to Parkinson's disease: role of functional imaging.

Authors:  Chong Sik Lee; Sun Ju Chung; Jae Seung Kim
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

Review 9.  Therapy of Parkinson's Disease Subtypes.

Authors:  Connie Marras; K Ray Chaudhuri; Nataliya Titova; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

10.  The effect of Parkinson's disease on interference control during action selection.

Authors:  S A Wylie; W P M van den Wildenberg; K R Ridderinkhof; T R Bashore; V D Powell; C A Manning; G F Wooten
Journal:  Neuropsychologia       Date:  2008-08-09       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.